Breaking News
December 12, 2018 - The Science of Healthy Aging
December 12, 2018 - Yes to yoghurt and cheese: New improved Mediterranean diet
December 12, 2018 - Researchers uncover a number of previously unknown insecticide resistance mechanisms
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
December 12, 2018 - FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
December 12, 2018 - Presence of antiphospholipid antibodies tied to first-time MI
December 12, 2018 - New study could help inform research on preventing falls
December 12, 2018 - Women and men with heart attack symptoms receive different care from EMS
December 12, 2018 - Disrupted biological clock can contribute to onset of diseases, USC study shows
December 12, 2018 - New publications generate controversy over the value of reducing salt consumption in populations
December 12, 2018 - New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity
December 12, 2018 - Specific class of biomarkers can accurately indicate the severity of cancer
December 12, 2018 - Meds Taken Do Not Vary With ADL Impairment in Heart Failure
December 12, 2018 - Long-term study shows that HIV-2 is deadlier than previously thought
December 12, 2018 - People living near oil and gas wells show early signs of cardiovascular disease
December 12, 2018 - IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony
December 12, 2018 - People who eat red meat have high levels of chemical associated with heart disease, study finds
December 12, 2018 - New method uses water molecules to unlock neurons’ secrets
December 12, 2018 - Genetics study offers hope for new acne treatment
December 12, 2018 - New computer model predicts prostate cancer progression
December 12, 2018 - Nobel Laureates lecture about immune checkpoint therapy for cancer treatment
December 12, 2018 - More Illnesses From Tainted Romaine Lettuce Reported
December 12, 2018 - Aspirin could reduce HIV infections in women
December 12, 2018 - The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors
December 12, 2018 - Insights into magnetotactic bacteria could guide development of biological nanorobots
December 12, 2018 - Sacrificial immune cells alert body to infection
December 12, 2018 - Low-salt diet may be more beneficial for females than males
December 12, 2018 - Major soil organic matter compound battles chronic wasting disease
December 12, 2018 - Findings may open up new ways to treat dwarfism and other ER-stress-related conditions
December 12, 2018 - New computational model provides clearer picture of shape-changing cells’ structure and mechanics
December 12, 2018 - 10 Facts on Patient Safety
December 12, 2018 - Poorest dying nearly 10 years younger than the rich in ‘deeply worrying’ trend for UK
December 12, 2018 - Innovative care model for children with ASD reduces use of behavioral drugs in ED
December 12, 2018 - Spending time in and around Hong Kong’s waters linked to better health and wellbeing
December 12, 2018 - Simple measures to prevent weight gain over Christmas
December 12, 2018 - Research advances offer hope for patient-tailored AML treatment
December 12, 2018 - Researchers discover a ‘blind spot’ in atomic force microscopy
December 12, 2018 - Sprayable gel could help prevent recurrences of cancer after surgery
December 12, 2018 - SLU researchers explore how fetal exposure to inflammation can alter immunity in newborns
December 12, 2018 - How do patients want to discuss symptoms with clinicians?
December 12, 2018 - Zinc chelation may be able to deliver drug to insulin-producing cells
December 12, 2018 - Brigham researchers develop automated, low-cost tool to predict a woman’s ovulation
December 12, 2018 - Some people with Type 2 diabetes may be testing their blood sugar more often than needed
December 12, 2018 - Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study
December 12, 2018 - Study provides new information regarding microRNA function in cellular homeostasis of zebrafish
December 12, 2018 - Study provides new understanding of mysterious ‘hereditary swelling’
December 12, 2018 - Researchers shed new light on how to combat Shiga and ricin toxins
December 12, 2018 - Pregnant Women Commonly Refuse Vaccines
December 12, 2018 - Drug treatment could offer new hope for some patients with brain bleeding
December 12, 2018 - Health care financial burden of animal-related injuries is growing, study says
December 12, 2018 - Macrophage cells could help repair the heart following a heart attack, study finds
December 12, 2018 - Researchers develop new system for efficiently producing human norovirus
December 12, 2018 - New artificial intelligence-based system to differentiate between different types of cancer cells
December 11, 2018 - Brazilian professors propose guidelines for therapeutic use of melatonin
December 11, 2018 - Healthy Lifestyle Lowers Odds of Breast Cancer’s Return
December 11, 2018 - New research identifies two genes linked to serious congenital heart condition
December 11, 2018 - NIH Director talks science, STEM careers with preteens
December 11, 2018 - Disabling a Cellular Antivirus System Could Improve Gene Therapy
December 11, 2018 - New tool swiftly provides accurate measure of patients’ cognitive difficulties
December 11, 2018 - NICE releases new guidelines for diagnosis and management of COPD
December 11, 2018 - Without Obamacare penalty, think it’ll be nice to drop your plan? Better think twice
December 11, 2018 - Researchers capture high-resolution X-ray and NMR image of key immune regulator
December 11, 2018 - Natural flavonoid is effective at treating leishmanisis infections, study shows
December 11, 2018 - Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows
December 11, 2018 - Study identifies how hantaviruses infect lung cells
December 11, 2018 - Improving PTSD care through genetics
December 11, 2018 - Dermatology providers show interest in recommending cannabinoids to patients
December 11, 2018 - Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression
December 11, 2018 - Four dried fruits have lower glycemic index than starchy foods, study finds
December 11, 2018 - Optimization of drug dose sizes can reduce pharmaceutical wastage
December 11, 2018 - Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed
December 11, 2018 - PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds
December 11, 2018 - Researchers aim to identify and target high blood pressure indicators
December 11, 2018 - Researchers identify immune cell subset that may drive chronic inflammation
December 11, 2018 - Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows
December 11, 2018 - One implant, two prices. It depends on who’s paying.
December 11, 2018 - Standardizing feeding practices improves growth trends for micro-preemies
December 11, 2018 - COPD Tied to Obesity in Male, Female Never-Smokers
ASCO Releases First Mesothelioma Guideline

ASCO Releases First Mesothelioma Guideline

image_pdfDownload PDFimage_print

Chemotherapy continues to be the mainstay of treatment for malignant pleural mesothelioma (MPM), as most patients have unresectable disease at diagnosis, according to a new clinical guideline from the American Society of Clinical Oncology (ASCO).

Patients who are surgical candidates should undergo procedures as part of multimodal therapy that includes chemotherapy with or without additional radiation therapy.

“Given the rarity of this disease [~3,000 cases a year], there have been few large randomized trials, especially for surgical management of this disease,” wrote members of the expert panel, chaired by Hedy L. Kindler, MD, of the University of Chicago, and Raffit Hassan, MD, of the National Cancer Institute.

“Although no new drugs have been approved for the treatment of MPM, since the approval of pemetrexed plus cisplatin in 2004, there have been significant recent advances in the understanding of the biology of mesothelioma and identifying new targets for therapy,” they added. “Ongoing clinical trials suggest promising activity of several new agents in MPM, but they are not sufficiently mature to make treatment recommendations.”

Published in the Journal of Clinical Oncology, the guideline is ASCO’s first ever for MPM and covers all aspects of disease management. The expert panel produced more than 60 recommendations covering five areas of clinical management: diagnosis, staging, chemotherapy, surgery, and radiation therapy. Key recommendations include:

Diagnosis — An initial thoracentisis for all symptomatic patients; thorascopic biopsy of all patients for whom antineoplastic treatment is planned; open pleural biopsy if thorascopic biopsy is not feasible; core needle biopsy if neither thorascopic or open pleural biopsy is feasible

Staging — Contrast CT scan of the chest and upper abdomen for initial staging; FDG-PET/CT advisable except for patients not being considered for definitive surgical resection; dedicated abdominal CT scan with or without pelvic imaging if initial staging suggests metastatic disease; MRI (preferably with contrast) may be obtained to assess tumor invasion into the diaphragm; chest wall, mediastinum, and other areas.

Chemotherapy — Chemotherapy should be offered, as it has been shown to improve survival and quality of life; a trial of observation may be offered for asymptomatic patients prior to initiation of chemotherapy; single-agent chemotherapy or palliative care may be offered to selected patients with poor performance status; preferred first-line chemotherapy of pemetrexed-cisplatin doublet, or referral to a clinical trial; addition of bevacizumab (Avastin) to pemetrexed-cisplatin improved survival in selected patients and may be offered; bevacizumab not recommend for patients with performance status 2, significant cardiovascular comorbidity, uncontrolled hypertension, age >75, or bleeding/clotting risk.

Surgery — Maximal surgical cytoreduction strongly recommended for selected patients with early-stage disease; single-modality surgery generally insufficient — additional treatment needed, either systemic or radiation therapy; neoadjuvant chemotherapy recommended for patients with transdiaphragmatic disease, multifocal chest-wall invasion, or histologically confirmed contralateral mediastinal or supraclavicular lymph node involvement; no benefit of surgery for patients with sarcomatoid mesothelioma.

Radiotherapy — Prophylactic irradiation of intervention tracts not recommended; adjuvant radiation therapy recommended after resection of histologically positive intervention tracts; palliative radiation therapy recommended for symptomatic disease; radiation therapy may be offered for localized asymptomatic recurrence; hemothoracic adjuvant or neoadjuvant radiation therapy may be offered to patients undergoing non-lung sparing cytoreductive surgery.

Kindler disclosed relationships with Aduro Biotech, MedImmune, Bayer HealthCare, Celgene, GlaxoSmithKline, AstraZeneca, Merck, Bristol-MyersSquibb, Boehringer Ingelheim, Ipsen, Erytech Pharma, Five Prime Therapeutics, Merck, Verastem, and Eli Lilly. Several coauthors disclosed relationships with multiple commercial entities.

2018-01-26T17:15:00-0500

Tagged with:

About author

Related Articles